Article Information
History
- May 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Azita H. Talasaz, PharmD1,2,3,
- Parham Sadeghipour, MD4,
- Maryam Aghakouchakzadeh, PharmD1,
- Isaac Dreyfus, MD5,
- Hessam Kakavand, PharmD1,
- Hamid Ariannejad, MD2,
- Aakriti Gupta, MD, MS5,6,7,
- Mahesh V. Madhavan, MD, MS5,6,
- Benjamin W. Van Tassell, PharmD3,8,
- David Jimenez, MD, PhD9,
- Manuel Monreal, MD, PhD10,
- Muthiah Vaduganathan, MD, MPH11,
- John Fanikos, R.Ph, MBA12,
- Dave L Dixon, PharmD3,8,
- Gregory Piazza, MD, MS11,
- Sahil A. Parikh, MD5,6,
- Deepak L. Bhatt, MD, MPH11,
- Gregory YH Lip, MD13,14,
- Gregg W. Stone, MD6,15,
- Harlan M. Krumholz, MD, SM7,16,17,
- Peter Libby, MD11,
- Samuel Z. Goldhaber, MD11 and
- Behnood Bikdeli, MD, MS7,8,11,*
- 1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
- 2Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
- 3Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA
- 4Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
- 5NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York
- 6Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA
- 7Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, CT, USA
- 8Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA
- 9Respiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (Instituto de Ramón y Cajal de Investigación Sanitaria), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain
- 10Department of Internal Medicine, Hospital Universitari Germans Trials i Pujol, Universidad Católica San Antonio de Murcia, Barcelona, Spain
- 11Division of cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 12Department of Pharmacy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 13Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, United Kingdom
- 14Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
- 15Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 16Department of Health Policy and Administration, Yale School of Public Health, New Haven, CT, USA
- 17Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- ↵*ADDRESS FOR CORRESPONDENCE: Dr. Bikdeli, Cardiovascular Medicine Division, Brigham and Women’s Hospital, 75Francis Street, Shapiro 5, Suite 5156. Boston, MA 02115; Phone: (617) 732-6984, Fax: (617) 738-7652, Email: bbikdeli{at}bwh.harvard.edu, Behnood.bikdeli{at}yale.edu
Posted May 05, 2021.
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
